Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis
Sanofi Healthcare India Pvt. Ltd. has taken a significant step forward in treating atopic dermatitis, a chronic inflammatory skin disease,...